Observational studyFrontiers in public health2025
Parent and caregiver perceptions of cannabidiol products may put children at risk for unintentional exposure.
Observational study in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Rapid growth in the cannabidiol (CBD) market has been temporally associated with increasing emergency department (ED) visits related to cannabis exposure in young children. This study examined the prevalence of CBD products among individuals with and without children in the household and described their general perceptions of CBD products to assess potential risks to children. Methods: A prospective observational study was performed at a single academic hospital in the southeastern US. Flyers with a QR code linked to an online survey were posted in the adult and children's EDs and pediatric outpatient clinic from August 2024 to May 2025. Participants indicated their age, whether they lived with/cared for children, whether they keep CBD products in the home, and answered general knowledge questions regarding CBD products. Chi-square analysis was used to compare responses across groups with Results: Eight hundred and twenty-six eligible respondents completed the survey. Those with CBD products in their household were more likely than those without CBD products to believe these products were safe for adults ( Conclusion: Significant inconsistency exists between households with CBD products and households without understanding the potential risks of CBD products. This may put children of households with CBD products at risk of accidental injuries. Efforts should be made towards increasing public health messaging regarding CBD products and potential THC exposure for parents, guardians, and medical professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.